PROGRAM
2020 Annual Meeting: March 5-7, 2020
Substance Use, Substance Use Disorders: Changing Concepts, Changing Patterns
The last two decades have seen enormous changes in public perceptions, laws and policies regarding substance use and substance use disorders. During this time, alcohol and drug use has increased markedly, especially opioids, marijuana and alcohol, leading to an opioid crisis and much debate about all of these substances. Research on substance use, its antecedents and consequences has seen substantial advances, from neurofunctioning to multi-level models of policy effects. At the same time, much remains to be learned. The 2020 APPA conference will present many of these areas, including many of the major studies are now underway that promise to provide important new information in the coming years. Major advances in behavioral and pharmacologic treatments have also been made, with more to be learned and done to better disseminate effective prevention efforts, and evidence-based treatments to those in need. The conference will also cover differences in important population subgroups (women, race/ethnic group), variation by life-cycle stage, stress, psychiatric comorbidity and suicide.
Speakers include NIDA and NIAAA directors, and internationally recognized leaders and experts in the areas to be presented. The conference will provide a lively interdisciplinary forum to discuss all of these issues, as well as considering important future directions.
Deborah S. Hasin, PhD
President 2020
PROGRAM
(Downloadable Flyer)
Thursday, March 5 | Friday, March 6 | Saturday, March 6
Thursday, March 5, 2020
9:00 AM – 10:15 AM Session 1: The View From National Institutes of Health
9:00 AM - 9:10 AM Welcoming Remarks
Deborah Hasin, PhD, Professor of Epidemiology; Columbia University
Chair
9:10 AM - 9:35 AM The View From NIAAA
George Koob, PhD, NIAAA Director
9:35 AM - 10:00 AM The View From NIDA
Nora Volkow, MD, NIDA Director
10:00 AM - 10:15 AM Discussion
10:15 AM - 10:30 AM Break
10:30 AM – 11:55 AM Session 2: Policy
Silvia Martins, MD, PhD, Associate Professor of Epidemiology, Director, Center for Policy and Health Initiatives for Opioids and Other Substances (PHIOS), Columbia University
Chair & Discussant
10:30 AM - 10:55 AM How can we Reverse the Tide of the Opioid Overdose Epidemic? Evidence on the Impact of Policy Solutions
Magdalena Cerdá, PhD, Associate Professor; Director, Center for Opioid Epidemiology and Policy, New York University
10:55 AM - 11:20 AM The Evolution of Marijuana Policy and how it has Shaped Marijuana Markets
Rosalie Pacula, PhD, Professor and Chair, School of Public Policy, University of Southern California
11:20 AM - 11:45 AM Recent Developments and Dynamics Between Opioid-Related Harms and Medical Cannabis Use in Canada
Benedikt Fischer, PhD, Professor, University of Toronto
11:45 AM - 12:00 PM Discussion
12:00 PM - 12:20 PM Oral Poster Presentations
12:00 PM - 12:05 PM Parenting and Youth Cannabis Use
Alexandra Pestropo, MD, MSc, Columbia University
12:05 PM - 12:10 PM Prefrontal Responses to Monetary Rewards and Future Substance Use
Corinne Bart, BA, Temple University
12:10 PM - 12:15 PM Z-Drugs, Distress, Benzodiazepines, & Other Depressant Recreational Drugs
Vitor Tardelli, MD, Universidade Federal de Sao Paulo
12:15 PM - 12:20 PM Firearm Suicide Mortality in ED Patients
Sidra Goldman-Mellor, PhD, University of California at Merced
12:20 PM - 1:20 PM Lunch (On Your Own)
1:20 PM – 2:50 PM Session 3: Epidemiology
Charles Branas, PhD, Chair, Department of Epidemiology, Mailman School of Public Health, Columbia University
Chair & Discussant
1:20 PM - 1:45 PM Age, Period, and Cohort Effects in Substance Use and Mental Health in the 21st Century
Katherine Keyes, PhD, Associate Professor of Epidemiology, Co-Director, Psychiatric Epi Training Program, Columbia University
1:45 PM - 2:10 PM Breaking the Intergenerational Cycle of Adversity: Substance Abuse in the Boricua Youth Study
Christiane Duarte, PhD, Lambert Professor of Psychiatry; Director, Child Mental Health Disparities Group, Columbia University
2:10 PM - 2:35 PM Racial Inequity in Psychiatric and Substance Use Disorders Among African Americans
Debra Furr-Holden, PhD, Mott Endowed Professor; Director, Flint Center for Health Equity Solutions, Michigan State University
2:35 PM - 2:50 PM Discussion
2:50 PM - 3:15 PM Presentation of the Hamilton Award
Deborah Hasin, PhD, Columbia University
3:15 PM - 3:30 PM Break
3:30 PM – 5:25 PM Session 4: Neurofunctioning and Genetics
Diana Martinez, MD, Professor, Columbia University Department of Psychiatry
Chair & Discussant
3:30 PM - 3:55 PM Glutamate and the Neurobiology of Human Alcoholism
John Krystal, MD, Chair, Yale University Department of Psychiatry
3:55 PM - 4:20 PM Gender, Stress, & Substance Use Disorders
Rajita Sinha, PhD, Foundations Fund Professor; Director, Yale Interdisciplinary Stress Center, Yale University Department of Psychiatry
4:20 PM - 4:45 PM Genetics of Substance Disorders: Million Veteran Sample
Joel Gelernter, MD, Foundations Fund Professor; Director, Division of Human Genetics, Yale University Department of Psychiatry
4:45 PM - 5:10 PM Adolescent Brain & Cognitive Development (ABCD) Study
Sandra Brown, PhD, Distinguished Professor of Psychology and Psychiatry; Vice Chancellor for Research, University of California, San Diego
5:10 PM - 5:25 PM Discussion
Friday, March 6, 2020
9:30 AM – 10:40 AM, Session 5: Measurement: Diagnosis, Outcomes
Edward Nunes, MD, Professor of Psychiatry, Columbia University
Chair & Discussant
9:30 AM - 9:35 AM Presentation of the Zubin Award
Bridget Grant, PhD, Former Director, NIAAA Lab of Epidemiology
9:35 AM - 10:00 AM Beyond Traditional Outcome Measures for SUD's
Eric Strain, MD, Johns Hopkins University
10:00 AM - 10:25 AM Meaningful Clinical Trial Endpoints
Stephanie O’Malley, PhD, Professor of Psychiatry; Director, Substance Abuse Research Division, Yale University
10:25 AM - 10:40 AM Discussion
10:40 AM - 10:55 AM Break
10:55 AM – 12:15 PM Session 6: Exposure Consequences I
Jill Harkavy-Friedman, PhD, Associate Professor of Clinical Psychology, in Psychiatry, Columbia University; American Foundation for Suicide Prevention
Chair & Discussant
10:55 AM - 11:20 AM Cannabis and Psychosis
Robin Murray, MD, Professor of Psychiatry (and former Dean), Institute of Psychiatry, Kings College London
11:20 AM - 11:45 AM Substance Use, Overdose and Suicide
Amy Bohnert, PhD, Associate Professor; Co-director, Mental Health Innovation, Services and Outcomes Program, University of Michigan
11:45 AM - 12:10 PM Predicting Suicide Among Persons With Substance Use Disorders in the Population of Denmark
Jaimie Gradus PhD, Associate Professor, Epidemiology/Psychiatry, Boston University
12:10 PM - 12:25 PM Discussion
12:25 PM – 1:25 PM APPA Annual Business Meeting
1:25 PM - 2:15 PM Lunch (On Your Own)
2:15 PM – 4:05 PM Session 7: Exposure Consequences II
Alan Budney, PhD, Professor, Dartmouth College
Chair & Discussant
2:15 PM - 2:40 PM Linking Maternal Risk Traits to Specific Child Diagnoses in Fetal Alcohol Spectrum Disorders (FASD)
Philip May, PhD, Professor, Global Public Health, University of North Carolina
2:40 PM - 3:05 PM Alcohol Stimulating and Sedating Effects
Andrea King, PhD, Professor of Psychiatry, Director, Addiction Research Laboratory, University of Chicago
3:05 PM - 3:30 PM The Risks and Benefits of Naloxone Prescribing to Drug Users: A Randomized, Controlled Trial
Sandra Comer, PhD, Professor of Psychiatry; Director, Opioid Laboratory, Columbia University
3:30 PM - 3:55 PM Cannabis Use Disorder: Current Perspectives
Margaret Haney, PhD, Professor of Psychiatry, Director, Cannabis Research Laboratory, Columbia University
3:55 PM - 4:10 PM Discussion
4:10 PM - 4:25 PM Break
4:25 PM - 4:50 PM Presentation of the Hoch Award
Mark Olfson, MD, Professor of Psychiatry, Columbia University; Co-Director, AHRQ Center for Education & Research on Mental Health Therapeutics
4:50 PM - 5:00 PM Discussion
Saturday, March 7, 2020
8:00 AM – 9:00 AM Early Career Investigators Round Table Breakfast
9:00 AM - 9:20 AM Presentation of the Robins-Guze Award
9:20 AM – 10:20 AM Session 8: Evidence-Based Treatments and Their Dissemination
John Rotrosen, MD, Professor, Department of Psychiatry, New York University
Chair & Discussant
9:20 AM - 9:45 AM Pharmacotherapy and Pharmacogenetics of Alcohol Use Disorder
Henry Kranzler, MD, Professor of Psychiatry; Director, Center for Studies of Addiction, University of Pennsylvania
9:45 AM - 10:10 AM Pharmacological Treatment, Opioids
Joshua Lee, MD, Associate Professor; Director, ABAM Fellowship in Addiction Medicine, New York University
10:10 AM - 10:20 AM Discussion
10:20 AM - 10:35 AM Break
10:35 AM - 11:00 AM Behavioral Treatments for Substance Use Disorders
Katherine Carroll, PhD, Kent Professor of Psychiatry; Director, Psychosocial Research on Addictions, Yale University
11:00 AM - 11:25 AM Alcohol and Other Drug Use Screening and Intervention: Efficacy, Effectiveness, Both, or Neither?
Richard Saitz, MD, Professor and Chair, Community Health Services, Boston University School of Public Health
11:25 AM - 11:45 AM Discussion
Meeting Concludes
APPA 2019-2020 Council
President
Deborah S. Hasin, PhD (Columbia University)
President Elect
James Potash, MD (Johns Hopkins University)
Vice President
Kathleen Merikangas, PhD (National Institute of Mental Health)
Secretary
William S. Stone, PhD (Harvard Medical School)
Treasurer
Joshua Breslau, ScD (RAND Corporation)
Membership Chair
Helen Wilson, PhD (Stanford University)
Coordinator
Jo-Ann L. Donatelli, PhD (Brown University)
Councilors
Raymond DePaulo, MD (Johns Hopkins University School of Medicine)
Stephen E. Gilman, ScD (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
Michael J. Lyons, PhD (Boston University) (Past President)
Susan L. Santangelo, ScD (Maine Medical Center)
|
